Osteoarthritis is the most common form of arthritis which causes pain, swelling, and reduced motion in the joints. Usually, osteoarthritis affected joints are inclusive of hands, knees, hips and spine. The rising geriatric and obese population are spurring the detection of osteoarthritis globally. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios. The market is anticipated to develop at a 6.8% CAGR in the forecast period.
The Global Osteoarthritis Market has been segmented on the basis of diagnosis, treatment, type, and end users.
By type, the osteoarthritis market is segmented into wrist osteoarthritis, hip osteoarthritis, spinal osteoarthritis, and others.
By diagnosis, the market is segmented into joint fluid analysis, imaging, and others.
The treatment segment comprises surgery, medication, therapy, and others.
Get PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1609
Considering the end user segment, the market is segmented into medical institutes, hospitals & clinics, research organization, and others. Of these, the hospitals & clinics segment will gain prominence in the coming years due to acceptance of advanced treatment options, which require hospitalization. Moreover, favorable reimbursement policies will encourage the market’s growth in the segment.
Osteoarthritis Market – Highlights
The Global Osteoarthritis Market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 6.8% during the forecast period (2017-2023).
The surge in the global osteoarthritis market is mainly due to the growing geriatric population, surging demand for minimally invasive surgical procedures, and high prevalence of osteoarthritis across the globe. Growth in the geriatric population has resulted in higher prevalence of osteoarthritis among the aging population. It is considered one of the most common joint disease, generally found in people of more than 65 years. It is further accompanied by reduced quality of life and mortality. According to the WHO, osteoarthritis is considered one of the ten most disabling diseases, especially in the developed economies.
Increased demand for minimally invasive surgical procedures in order to treat osteoarthritis is the primary factor triggering the demand from the osteoarthritis market. For instance, MAKOplasty is a minimally invasive knee surgery, which helps to relieve pain caused by osteoarthritis. Government support for funding and ongoing research and development are further creating new growth opportunities for the market.
On the contrary, low per capita income, especially in the developing economies, coupled with the side effects associated with the treatment procedures are likely to restrict the market growth in the coming years.
August 2019: A team of researchers from the University Hospital of Basel and Polytechnic University of Milan has recently developed a microfluid chip, which contains cartilage and can be subjected to mechanical stress.
March 2019 – Researchers from the Kennedy Institute of Rheumatology at the University of Oxford, and Jenner Institute have collaboratively developed a vaccine that could be used to treat chronic pain caused by osteoarthritis. The virus-like particle vaccine is capable of triggering the immune system to produce antibodies which would help to block naturally-occurring NGF and alleviate osteoarthritis pain.
Key Players – Osteoarthritis Market
The top players operating in the osteoarthritis market include
- Novartis AG (Europe),
- Abbott. (U.S.),
- Eli Lilly and Company. (U.S.),
- Pfizer Inc. (U.S.),
- Merck Sharp & Dohme Corp. (U.S.),
- ABIOGEN PHARMA S.p.A (Europe),
- Ampio Pharmaceuticals Inc. (U.S.),
- TissueGene Inc. (U.S.),
- Regeneron (U.S.),
Regional Analysis – Osteoarthritis Market
Geographically, the osteoarthritis market spans across Europe, America, Asia Pacific, and the Middle East & Africa.
Considering the global scenario, America is estimated to dominate the osteoarthritis market, mainly due to the presence of a well-developed healthcare sector, coupled with the existence of a huge patient pool. Rising healthcare expenditure along with changing lifestyle has further boosted the market demand in the region. Increased prevalence of osteoarthritis, resulting in disability and soaring demand for disease-modifying drugs and advanced therapies are estimated to encourage the market growth in the coming years.
Europe acquires the second spot in the global market and will catch up with the American market in the long run. The growth is credited to the availability of funds for research, rising expenditure on healthcare, and the presence of a huge patient population. Support from the government for research and development and the presence of well-developed healthcare infrastructure are some of the other factors encouraging the market to a great extent.
Meanwhile, the Asia Pacific is predicted to expand at the fastest rate, owing to the presence of a huge patient pool, huge opportunity in the market, and constantly developing countries like China and India. Increasing healthcare expenditure and favorable government policies further influences the market growth in the region.
Get Prime Discount on Premium Report @ https://www.marketresearchfuture.com/check-discount/1609
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312